Showing 1061-1070 of 1645 results for "".
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0606Epilepsy-pdf/31304/Epilepsy patients face a significantly elevated risk of skeletal fractures, estimated to be two to seven times higher than in individuals without epilepsy. This increased vulnerability is attributed to multiple factors, including the direct impact of seizures, fall-related injuries during seizure ep
- Savvy Contracting Strategies for Clinical Research Trialshttps://practicalneurology.com/columns/practice-management/savvy-contracting-strategies-for-clinical-research-trials/31310/Participating in clinical trials offers neurologists the opportunity to advance medical knowledge, provide patients with access to innovative treatments, and generate additional revenue for their practices. However, engaging in clinical research involves navigating various challenges to ensure profi
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1005epilepsy-pdf/31388/Exploring the Complex Interplay Between Epilepsy and Mood DisordersEpilepsy and depression frequently coexist as comorbid conditions, significantly impacting patients' quality of life. Comorbidity, defined as the simultaneous occurrence of two or more diseases, does not necessarily indicate causalit
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN1005DementiaInsights-pdf/31386/Medicare’s Limited Approval of PET Scans in Dementia: Implications for Clinical PracticeIn September 2004, the Centers for Medicare and Medicaid Services (CMS) approved the use of positron emission tomography (PET) scans for dementia diagnosis, specifically to differentiate Alzheimer’s disease (AD)
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0905-dementiainsights-pdf/31397/Navigating Evidence-Based Medicine and Alternative Treatments in Dementia CareIn the evolving landscape of neurology, the transition from a paternalistic approach to evidence-based medicine (EBM) has significantly reshaped dementia care. Dr. David S. Geldmacher highlights the complexities that EBM i
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0805DementiaInsights-pdf/31414/Statins and Alzheimer's Disease: Evaluating the Potential for PreventionRecent discussions in clinical neurology have revisited the intriguing possibility that statin-type HMG-CoA reductase inhibitors, widely prescribed for hyperlipidemia, may play a role in preventing or treating Alzheimer’s Diseas
- Will the Medical Liability Crisis Hammer Your Practice?https://practicalneurology.com/archives/2005-june/PN0605malpractice-pdf/31441/Medical Malpractice Reform: Navigating the Ongoing Liability CrisisMedical malpractice reform remains a critical yet contentious issue within the healthcare sector, as highlighted in the June 2005 issue of *Practical Neurology*. Despite sustained advocacy by physicians, national progress on liabilit
- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/imaging-testing/PN0605ExpertOpinion-pdf/31440/Unilateral Paresthesias Due to Hyperventilation Syndrome: A Clinical InsightIn the article "Unilateral Paresthesias Due to Hyperventilation Syndrome," Dr. Randolph W. Evans presents a comprehensive analysis of a 53-year-old male patient exhibiting dizziness and tingling in the left ankle, initially
- Vascular Clinichttps://practicalneurology.com/diseases-diagnoses/stroke/PN0505Vascular-pdf/31460/Intracranial stenosis, responsible for 10-15% of all strokes and more prevalent among non-Caucasian populations such as Asians and African Americans, remains a critical yet under-researched area in vascular neurology. Historically, the medical management of intracranial stenosis lacked robust prospe
- Vascular Clinichttps://practicalneurology.com/diseases-diagnoses/stroke/0305VasClinicforWeb-pdf/31476/Recent developments in antiplatelet therapy for ischemic stroke patients have prompted a reevaluation of clopidogrel (Plavix) usage, particularly in those with aspirin intolerance. The Management of Atherothrombosis with Clopidogrel in High-risk Patients (MATCH) trial previously indicated that combi